These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes. Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. Hydes TJ; Summers N; Brown E; Alam U; Thomaides-Brears H; Wilding JPH; Cuthbertson DJ Diabet Med; 2020 Nov; 37(11):1793-1806. PubMed ID: 32619031 [TBL] [Abstract][Full Text] [Related]
8. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review. Petäjä EM; Yki-Järvinen H Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128911 [TBL] [Abstract][Full Text] [Related]
9. A review of non-alcoholic fatty liver disease in non-obese and lean individuals. Ahadi M; Molooghi K; Masoudifar N; Namdar AB; Vossoughinia H; Farzanehfar M J Gastroenterol Hepatol; 2021 Jun; 36(6):1497-1507. PubMed ID: 33217052 [TBL] [Abstract][Full Text] [Related]
10. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947 [TBL] [Abstract][Full Text] [Related]
11. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease. Nascimbeni F; Bedossa P; Fedchuk L; Pais R; Charlotte F; Lebray P; Poynard T; Ratziu V; J Hepatol; 2020 May; 72(5):828-838. PubMed ID: 31862486 [TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome. Abruzzese GA; Motta AB Curr Pharm Des; 2015; 21(35):5144-50. PubMed ID: 26412465 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321 [TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488 [TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237 [TBL] [Abstract][Full Text] [Related]
17. Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease. Weyler J; Verrijken A; Hornemann T; Vonghia L; Dirinck E; von Eckardstein A; Vanwolleghem T; Michielsen P; Peiffer F; Driessen A; Hubens G; Staels B; Francque S; Van Gaal L Acta Diabetol; 2021 Mar; 58(3):319-327. PubMed ID: 33084982 [TBL] [Abstract][Full Text] [Related]
18. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. Fujii H; Kawada N; Japan Study Group Of Nafld Jsg-Nafld Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485838 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD? Gastaldelli A Clin Sci (Lond); 2017 Nov; 131(22):2701-2704. PubMed ID: 29109303 [TBL] [Abstract][Full Text] [Related]
20. Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables. Vespasiani-Gentilucci U; Gallo P; Dell'Unto C; Volpentesta M; Antonelli-Incalzi R; Picardi A World J Gastroenterol; 2018 Nov; 24(43):4835-4845. PubMed ID: 30487694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]